Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial

By sjmartinez • May 16, 2025

Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie K, Litwin MS, Donin NM, Rettig M, Nickols NG, Cao M, Liauw SL, Steinberg ML, Kishan AU. Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 15. doi: 10.1001/jamaoncol.2025.1059. Epub ahead of print. PMID: 40372727.

Tags: DOM STAT, General Internal Medicine, Hematology/Oncology, Publications, Veterans Administration

Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries

Zhou FF, Essien UR, Souza JM, Sarkisian CA, Damberg CL, Landon BE, Mafi JN. Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries. JAMA Netw[...]

Digital Health Technology Use Among Spanish Speakers in the US: A Scoping Review

Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among[...]

Abridging the 22-Item Sino-Nasal Outcome Test (SNOT-22) in People With Cystic Fibrosis: Limiting Survey Burden

Chen H, Fischer JL, Tibbe TD, Sedaghat AR, Han EJ, Mace JC, Alt JA, Bodner TE, Chowdhury NI, Gao YA, Hwang PH, Khanwalkar A, Kimple[...]